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Summary
Many bacterial pathogens utilize a type III secretion
system (T3SS) to inject virulence effector proteins into
host cells during infection. Previously, we found that
enteropathogenic Escherichia coli (EPEC) uses the
type III effector, NleE, to block the inflammatory
response by inhibiting IkB degradation and nuclear
translocation of the p65 subunit of NF-kB. Here we
screened further effectors with unknown function for
their capacity to prevent p65 nuclear translocation. We
observed that ectopic expression of GFP–NleC in
HeLa cells led to the degradation of p65. Delivery of
NleC by the T3SS of EPEC also induced degradation of
p65 in infected cells as well as other NF-kB compo-
nents, c-Rel and p50. Recombinant His6-NleC induced
p65 and p50 cleavage in HeLa cell lysates and muta-
tion of a consensus zinc metalloprotease motif, HEIIH,
abrogated NleC proteolytic activity. NleC inhibited IL-8
production during prolonged EPEC infection of HeLa
cells in a protease activity-dependent manner. A
double nleE/nleC mutant was further impaired for its
ability to inhibit IL-8 secretion than either a single nleE
or a single nleC mutant. We conclude that NleC is a
type III effector protease that degrades NF-kB thereby
contributing the arsenal of bacterial effectors that
inhibit innate immune activation.
Introduction
Bacterial pathogens such as enteropathogenic Escheri-
chia coli (EPEC) and enterohaemorrhagic E. coli (EHEC)
utilize a type III secretion system (T3SS) to translocate
multiple effector proteins into infected cells (Coburn et al.,
2007). The T3SS of EPEC and EHEC is encoded within the
locus of enterocyte effacement (LEE) pathogenicity island
which is essential for the ability of the pathogens to cause
attaching and effacing (A/E) lesions (McDaniel and Kaper,
1997). A/E lesions are characterized by intimate attach-
ment of the bacteria to the host cell surface and the
recruitment of filamentous actin beneath the adherent
bacteria (Frankel et al., 1998). Intimate attachment results
from a high-affinity interaction between the outer mem-
brane adhesin, intimin and its receptor, Tir, which is trans-
located into the host cell membrane by the LEE-encoded
T3SS (Kenny et al., 1997; Hartland et al., 1999; Luo et al.,
2000).
Apart from A/E lesion formation, effectors translocated
by the LEE encoded T3SS mediate a range of patho-
physiological events including the disruption of cellular
tight junctions, inhibition of apoptosis and the suppres-
sion of innate immune signalling pathways. Recent
advances in the study of EPEC/EHEC effector biology
have revealed important new biochemical activities for
many effectors with previously unknown function. For
example, NleH is a potent inhibitor of apoptosis that acts
by binding Bax inhibitor 1 (Hemrajani et al., 2010). Other
effectors with newly ascribed functions in promoting cell
survival and cell attachment are EspO and EspZ. EspO
and its homologue, OspE, in Shigella promote host cell
attachment to the basement membrane by interacting
with integrin-linked kinase (ILK) and blocking the turn-
over of focal adhesions (Kim et al., 2009). EspZ also
prevents host cell detachment by interacting with the
host protein CD98 and enhancing the stability of focal
adhesions during infection (Shames et al., 2010). The
NleG type III effectors are a newly described family of
U-Box E3 ubiquitin ligases. Although their various
targets are unknown, the NleG proteins are likely to
direct the turnover of host cell proteins and/or other type
III effectors by the cell proteasome through the host cell
ubiquitination pathway (Wu et al., 2010). Other EPEC/
EHEC effectors interfere with host cell Rho GTPase
activity. EspT is a rare WxxxE effector that confers an
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invasive ability on EPEC by activating Rac1 and Cdc42,
thereby stimulating membrane ruffling and lamellipodia
formation (Bulgin et al., 2009). EspM2 is another WxxxE
effector that acts as a RhoA guanine nucleotide exchange
factor (Arbeloa et al., 2010). EspH has a seemingly
opposing activity that involves binding the DH-PH domain
of multiple RhoGEFs, thereby preventing Rho nucleotide
exchange and enzyme activation (Dong et al., 2010). How
the overlapping and sometimes opposing activities of
these effectors are co-ordinated during infection remains
to be discovered.
The transcription factor NF-kB is a key regulator of
cytokine gene expression. In most tissues, the dominant
form of NF-kB comprises a dimer of the subunits p65 and
p50. However other NF-kB proteins can also form homo-
and heterodimers including c-Rel, RelB and p52. Together
these factors are termed Rel proteins as they all share an
N-terminal Rel homology domain which is involved in
dimerization. In resting cells, the p65/p50 dimer is held in
an inactive state by binding the inhibitor, IkB. Upon stimu-
lation by exogenous stimuli such as Toll-like receptor
(TLR) ligands or cytokines such as TNF and IL-1b, IkB is
phosphorylated, ubiquitinated and then degraded by the
cell proteasome (Li and Verma, 2002). The release of
p65/p50 from IkB allows the dimer to translocate through
the nuclear pore complex to the cell nucleus where p65
stimulates gene expression from NF-kB-dependent pro-
moters such as IL8 (Li and Verma, 2002). Recently, we
and another research group reported that the type III
effectors, NleE and NleB from EPEC, blocked activation
of NF-kB by inhibiting IkB degradation and p65 nuclear
translocation (Nadler et al., 2010; Newton et al., 2010;
Vossenkamper et al., 2010). This resulted in diminished
IL-8 secretion in response to natural infection and stimu-
lation with TNF. However, whereas NleE prevented both
TNF- and IL-1b-stimulated IkB degradation, NleB inhib-
ited the TNF pathway only suggesting that NleB and NleE
have complementary but independent activities (Newton
et al., 2010). In this study, we screened further effectors
with unknown function for their ability to inhibit the trans-
location of p65 to the cell nucleus. During this screen, we
observed that NleC induced degradation of p65 and other
NF-kB signalling components. We suggest that NleC is a
type III effector protease that acts synergistically with
NleE and NleB to suppress immune activation.
Results
NleC induces degradation of the p65 subunit of NF-kB
In this study we screened further T3SS effectors from
EPEC E2348/69 with no known function for their ability to
inhibit the translocation of p65 to the cell nucleus in
response to TNF or IL-1b using anti-p65 antibodies to
stain cells expressing GFP–effector fusions ectopically.
We observed that cells expressing GFP–NleC showed
significantly weaker p65 staining than cells expressing
GFP, GFP–NleE, GFP–NleD, GFP–NleF, GFP–NleG,
suggesting that p65 was undergoing degradation (Fig. 1).
The weak p65 staining was independent of stimulation
with TNF (Fig. 1).
To investigate whether NleC delivered by the LEE-
encoded T3SS could induce p65 degradation, we used
derivatives of wild-type EPEC E2348/69 to infect HeLa
cells. Successful infection was defined by a positive fluo-
rescent actin staining (FAS) test, which served as a
marker for the translocation of T3SS effectors. Although
little p65 degradation was evident upon a 4 h infection
with the wild-type strain EPEC E2348/69, the same wild-
type strain expressing NleC from an IPTG-inducible pro-
moter in pTrc99A (pNleC) induced clear degradation of
p65 (Fig. 2). To avoid potential effects on NF-kB signalling
from NleE and the two NleB homologues, NleB1 and
NleB2, we also infected HeLa cells with a double island
DPP4/IE6 mutant complemented with pNleC. The DPP4/
IE6 mutant lacks genes encoding seven effectors includ-
ing, NleE, NleB1, EspL, NleB2, NleC, NleD and NleG
(Newton et al., 2010). Whereas the DPP4/IE6 mutant had
no effect on levels of p65, DPP4/IE6 carrying pNleC
induced p65 degradation similar to E2348/69 (pNleC)
(Fig. 2).
NleC is a putative zinc metalloprotease
The effect of NleC on p65 suggested that NleC may have
protease activity. Analysis of the NleC amino acid
sequence using Prosite (Sigrist et al., 2010) identified a
putative consensus zinc metalloprotease active site,
HEIIH (Fig. 3A). We also previously described a putative
consensus zinc metalloprotease site, HELLH, in the
downstream effector, NleD (Fig. 3A) (Marches et al.,
2005). Both histidines within the consensus sequence of
zinc metalloproteases (HExxH) are involved in binding a
zinc ion that promotes nucleophilic attack on peptide
bonds using a water molecule at the active site (Potempa
and Pike, 2005).
To confirm the degradation of p65 by NleC, we infected
HeLa cells with derivatives of EPEC E2348/69 overex-
pressing NleC, NleD or NleE and performed an immuno-
blot with antibodies raised to the N-terminus of p65. NleD
and NleE were useful controls as NleD has no effect on
NF-kB activation but possesses a putative protease active
site while NleE inhibits NF-kB activation but has no con-
sensus protease site (Newton et al., 2010). In cells
infected with any of EPEC E2348/69 (pNleC), DPP4/IE6
(pNleC) or DPP4 (pNleC), the band corresponding to p65
was significantly reduced (Fig. 3B). None of the other
E2348/69 derivatives had any effect on levels of p65.
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We also examined the effect of NleC on other NF-kB
members (c-Rel and p50) and other host transcription
factors, STAT1 and Erk. Overexpression of NleC also
induced the degradation of c-Rel, and p50, but not STAT1,
Erk, actin or calnexin (Fig. 3B and data not shown).
Amino acid substitutions of the histidine residues in the
active site of zinc metalloproteases render the enzymes
non-functional (Jongeneel et al., 1989). Here we substi-
tuted His183 and His187 with alanine to test the effect of
the consensus sequence on p65 degradation. The inac-
tive form of NleC, NleCAEIIA, was then used to complement
an nleC mutant of EPEC (Marches et al., 2005). While
NleC expressed from pTrc99A induced degradation of
p65, p50 and c-Rel, NleCAEIIA was unable to degrade the
same Rel proteins (Fig. 3C). To determine if NleC directly
cleaved p65 and p50, we generated His6-NleC and
His6-NleCAEIIA and incubated the recombinant proteins
with HeLa lysates. Levels of p65 and p50 were detected
by immunoblot using antibodies to p65 and p50.
With increasing concentrations of His6-NleC but not
His6-NleCAEIIA, we observed increasing degradation of p65
and p50 suggesting that the metalloprotease acts directly
Fig. 1. Effect of ectopically expressed NleC
on p65 immunostaining. Representative
immunofluorescence fields of p65 degradation
using anti-p65 (red) in HeLa cells transfected
with pEGFP–C2 (GFP), pGFP–NleC
(GFP–NleC), pGFP–NleE, pGFP–NleD,
pGFP–NleF and pGFP–NleG (green) and left
unstimulated or stimulated with TNF for
30 min where indicated. Cell nuclei were
stained with DAPI (blue). Transfections and
staining were performed independently at
least three times per GFP–effector fusion.
Arrows indicate transfected cells with poor
p65 staining.
NleC targets inflammatory signalling 221
© 2011 Blackwell Publishing Ltd, Molecular Microbiology, 80, 219–230
on these substrates (Fig. 4). We assume the altered
migration of His6-NleCAEIIA (Fig. 4) was due to a change in
the charge of the mutant protein arising from the substi-
tution of two positively charged histidine residues with
non-polar alanine residues.
NleC acts synergistically with NleE
A remaining question in the proposed activity of NleC was
the lack of obvious p65 degradation by wild-type EPEC
E2348/69 during infection (Fig. 3B). This appeared to
Fig. 2. Effect of NleC on p65 during EPEC infection. Representative immunofluorescence fields showing p65 staining (green) in FAS-positive
HeLa cells (red) uninfected or infected for 4 h with wild-type EPEC E2348/69, a DPP4/IE6 double island mutant, DPP4/IE6 carrying the
overexpression vector pNleC or EPEC E2348/69 carrying the overexpression vector pNleC as indicated, and stained for nucleic acid with
DAPI (blue). Infections and staining were performed independently at least three times per EPEC E2348/69 derivative. Arrows indicate
FAS-positive lesions.
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relate to the amount of NleC injected by the T3SS since
overexpression of NleC in the wild-type background
induced a significant reduction in levels of p65 (Fig. 3B).
We postulated that NleC may preferentially target free
p65/p50 dimer released from the IkB complex. If this were
the case, p65 degradation by wild-type EPEC should be
evident after longer infection times and in the absence of
NleE, which inhibits IkB degradation. To test this hypoth-
esis we performed 2, 4 and 6 h infections with EPEC
E2348/69 and isogenic nleE and nleC mutants. While no
p65 degradation was evident in cells infected with wild-
type EPEC for 2 and 4 h (Fig. 5 and Newton et al., 2010),
wild-type infection induced significant p65 degradation
after 6 h (Fig. 5). The effect of NleC at 6 h may in part
arise from increased numbers following bacterial replica-
tion and/or an accumulation of NleC over time. However,
in the absence of nleE, where IkB is degraded and p65/
p50 dimer is released, reduced levels of p65 could be
observed 4 h after infection (Fig. 5). Thus, native levels of
NleC delivered by EPEC do induce p65 degradation but
this was only apparent in HeLa cells 6 h after infection or
at 4 h in the absence of NleE.
To confirm that NleC was responsible for the degrada-
tion of p65 at this later time point, we infected cells with
the nleC mutant complemented with pNleC or pNleCAEIIA.
NleC expressed from pTrc99A induced degradation of
p65 whereas NleCAEIIA lacked this activity (Fig. 6). There is
also some suggestion of cell loss at this prolonged time
point as all infected samples exhibited a trend towards
reduced levels of actin, although this was not significant
compared with the uninfected control sample (Figs 5 and
6).
NleC inhibits IL-8 secretion
We previously showed that an nleE mutant of EPEC had
a reduced capacity to inhibit IL-8 expression and secre-
tion during infection, although a T3SS system mutant was
even further impaired (Newton et al., 2010). Here we
found that the double PP4/IE6 island mutant which lacks
both nleE and nleC was unable to inhibit IL-8 secretion,
similar to a T3SS mutant (Fig. 7 and data not shown).
Complementation of PP4/IE6 with either pNleE or pNleC
but not pNleCAEIIA led to the inhibition of IL-8 secretion
similar to wild-type EPEC indicating that the effectors
Fig. 3. Effect of NleC on inflammatory
signalling mediators.
A. Alignment of the regions of NleC and NleD
containing the putative zinc metalloprotease
motif (underlined).
B and C. Representative immunoblots
showing degradation of inflammatory
signalling mediators in HeLa cells infected
with derivatives of EPEC E2348/69 for 4 h.
Cells were harvested for immunoblotting and
host proteins were detected with antibodies to
p65, p50, c-Rel, STAT1 and Erk. Infections
and immunoblotting were performed
independently at least three times per EPEC
E2348/69 derivative. Antibodies to actin were
used as loading control. UI, uninfected.
Fig. 4. Effect of recombinant NleC on the degradation of NF-kB.
Representative immunoblot showing degradation of Rel proteins in
HeLa cells incubated with increasing concentrations of recombinant
His6NleC and His6NleCAEIIA (0.01, 0.1, 0.5 and 1 mg) for 4 h.
Incubations were performed independently at least three times per
His6NleC derivative. Cells were harvested for immunoblotting and
Rel proteins were detected with antibodies to p65 and p50.
Antibodies to calnexin were used as loading control for HeLa
lysates. His6-tagged proteins were detected with anti-His
antibodies.
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have comparable functions (Fig. 7A). The nleE mutant
showed an impaired ability to inhibit IL-8 secretion 4 h
after infection but the level of IL-8 was still significantly
lower than that induced by the DPP4/IE6 double island
mutant, which also lacks nleC (Fig. 7A). Interestingly, 4 h
after infection, an nleC mutant inhibited IL-8 secretion to
the same degree as wild-type EPEC (Fig. 7A), suggesting
that NleE delivered by the nleC mutant was sufficient for
the suppression of immune activation at this time point.
Stimulation with TNF made little difference to the ability of
EPEC to inhibit IL-8 secretion (Fig. 7A).
To determine if NleC played a role in the inhibition of
IL-8 secretion, we examined the effect of prolonged EPEC
infection on IL-8 levels where we had previously seen
evidence of p65 degradation by wild-type EPEC due to
NleC activity (Figs 5 and 6). We compared IL-8 secretion
from cells infected for 6 h with wild-type EPEC, the DPP4/
IE6 double island mutant, the single DnleE and DnleC
mutants and a double DnleE/C mutant. At this time point,
the DnleC mutant still inhibited IL-8 secretion to wild-type
levels presumably due to NleE activity (Fig. 7B). In addi-
tion, at this time point there was now no significant differ-
ence in IL-8 secretion between the nleE mutant and wild-
type EPEC. In contrast, a double nleE/C mutant was
significantly impaired in its ability to inhibit IL-8 secretion
6 h after infection, suggesting that NleE and NleC act
synergistically (Fig. 7B). However, IL-8 secretion resulting
from infection with the DPP4/IE6 double island mutant
was still significantly greater than that induced by the
double nleE/C mutant indicating that further effectors
encoded within PP4 and/or IE6 may have an anti-
inflammatory role (Fig. 7B)
Discussion
Enteropathogenic E. coli and EHEC stimulate inflam-
matory signalling through TLR5 recognition of flagellin
(Miyamoto et al., 2006; Badea et al., 2009; Schuller et al.,
Fig. 5. Effect of EPEC infection on p65 degradation.
A. Immunoblot showing degradation of p65 in HeLa cells infected with derivatives of EPEC E2348/69 for 2, 4 and 6 h. Infections and
immunoblotting were performed independently at least three times per EPEC E2348/69 derivative and per time point. Cells were harvested for
immunoblotting and detected with antibodies to p65. Antibodies to actin were used as loading control. UI, uninfected.
B. Mean band intensity of immunoblots performed on HeLa cells infected with derivatives of EPEC E2348/69 and detected with antibodies to
p65 and actin as indicated. UI, uninfected. Results are expressed as the mean  SEM of three independent experiments. *P < 0.05 compared
with uninfected, unstimulated cells at each time point, one-way ANOVA.
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Fig. 6. Effect of prolonged EPEC infection on p65 degradation.
A. Immunoblot showing degradation of p65 in HeLa cells infected with derivatives of EPEC E2348/69 for 6 h. Infections and immunoblotting
were performed independently at least three times per EPEC E2348/69 derivative. Cells were harvested for immunoblotting and detected with
antibodies to p65. Antibodies to actin were used as loading control. UI, uninfected.
B. Mean band intensity of immunoblots performed on HeLa cells infected with derivatives of EPEC E2348/69 and detected with antibodies to
p65 and actin as indicated. Results are expressed as the mean  SEM of three independent experiments. *P < 0.05 compared with
uninfected, unstimulated cells at each time point, one-way ANOVA.
Fig. 7. Effect of nleE and nleC mutations on IL-8 secretion from infected HeLa cells.
A. HeLa cells were infected with derivatives of EPEC E2348/69 for 4 h and left unstimulated (light grey bars) or stimulated with TNF for 24 h
(dark grey bars). Results are the mean  SEM of at least three independent experiments carried out in duplicate. *P < 0.0001 compared with
uninfected, unstimulated cells, one-way ANOVA.
B. HeLa cells were infected with derivatives of EPEC E2348/69 for 6 h and left unstimulated (light grey bars). Results are the mean  SEM of
at least three independent experiments carried out in duplicate. *P < 0.0001 compared with uninfected, unstimulated cells, one-way ANOVA.
#DPP4/IE6 significantly greater than nleE/C double mutant P < 0.0001, unpaired two-tailed t-test.
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2009). Salmonella also stimulates TLR signalling (Tapping
et al., 2000; Hayashi et al., 2001) and, similar to Shigella,
activates intracellular NLRs that recognize bacterial
ligands such as flagellin, peptidoglycan and the T3SS
itself (Miao et al., 2006; 2010; Nigro et al., 2008). Intesti-
nal inflammation contributes to disease pathology but is
also required for pathogen control and clearance. Hence
many bacterial enteropathogens have acquired effectors
that modulate the inflammatory response as a way of
persisting in the host. Salmonella and Shigella secrete
multiple T3SS effectors that interfere with inflammatory
signalling and suppress cytokine production. For
example, OspF from Shigella and SpvC from Salmonella
are phosphothreonine lyases that target mitogen-
activated protein kinases (MAPKs) in the nucleus (Arbibe
et al., 2007; Kramer et al., 2007; Li et al., 2007). OspG
from Shigella is a protein kinase that binds ubiquitin-
conjugating enzymes and inhibits the ubiquitination and
degradation of phosphorylated IkB (Kim et al., 2005). In
addition, IpaH9.8 from Shigella and its homologue SspH1
from Salmonella traffic to the nucleus where they act as
E3 ubiquitin ligases that target selected signalling kinases
for proteosome-dependent degradation (Haraga and
Miller, 2006; Rohde et al., 2007; Ashida et al., 2010). The
activity of OspF, OspG, SpvC, IpaH9.8 and SspH 1 results
in the repression of NF-kB-dependent genes such as IL8
leading to immune suppression post bacterial invasion.
Recently, we and Nadler et al. found that NleE/OspZ, an
effector shared by A/E pathogens and Shigella, and NleB,
inhibited the degradation of IkB leading to reduced IL-8
production (Nadler et al., 2010; Newton et al., 2010; Vos-
senkamper et al., 2010).Although the mechanism of action
of NleE and NleB is still under investigation, here we
continued screening other type III effectors for their ability
to inhibit activation of inflammatory signalling. Our
approach was to express the effectors ectopically by trans-
fection as GFP-fusion proteins. Through this screening we
found that ectopic expression of GFP–NleC resulted in
degradation of the NF-kB subunit, p65. p65 degradation
was also evident upon translocation of NleC by the T3SS of
EPEC. Other Rel proteins, p50 and c-Rel, were also
affected by NleC but not the transcription factors, STAT1
and Erk. Degradation of the Rel proteins required the zinc
metalloprotease motif of NleC, H183EIIH, and recombinant
His6-NleC degraded p65 and p50 in HeLa cell lysates
suggesting direct cleavage by the protease effector.
Indeed, while this work was under review, two independent
studies demonstrated direct cleavage of recombinant p65
by NleC (Yen et al., 2010; Baruch et al., 2011). Both
studies also showed that p65 cleavage occurred at the
N-terminus in the Rel homology domain and that cleavage
was independent of the cell proteasome. A third study
confirmed proteasome-independent cleavage and sug-
gested that NleC also targets IkB (Muehlen et al., 2011).
In this study, we observed p65 degradation by wild-type
EPEC translocating native levels of NleC only after pro-
longed infection whereas p65 degradation was evident
earlier following infection with an nleE mutant. Although
further work is required to establish clearly the hierarchy
of T3SS effector activity, we are investigating a model
whereby NleE acts early to prevent IkB degradation and
p65/p50 release, while NleC acts later to degrade
unbound p65/p50 before cytokine gene transcription is
initiated in the cell nucleus. In support of this model, two
recent studies showed that NleC has activity in the cell
nucleus (Yen et al., 2010; Baruch et al., 2011). Therefore
the temporal and spatial regulation of NleC and NleE
activity may occur at several levels, namely gene tran-
scription, effector translocation and/or post-translocation
effector trafficking, which has been reported recently for
EPEC PDZ-binding effectors (Martinez et al., 2010).
NleC and NleE mediated inhibition of NF-kB activation
was mirrored in suppression of IL-8 secretion. IL-8 is an
NF-kB responsive gene and is a physiological readout of
NF-kB activity. Although nleC and nleE single mutants
showed wild-type levels of IL-8 inhibition following pro-
longed infection, an nleE/C double mutant was signifi-
cantly impaired for inhibition of IL-8 secretion. However,
this deficiency was not as great as the double island
mutant DPP4/IE6, suggesting that further effectors
encoded with in these genomic islands, such as NleD
which degrades the signalling kinase, JNK (Baruch et al.,
2011), contribute to the ability of EPEC to inhibit inflam-
matory signalling. The apparent redundancy in function
between NleE and NleC may also explain why previous
reports have failed to find a strong phenotype associated
with either an nleE or an nleC mutant during Citrobacter
rodentium infection of mice (Marches et al., 2005; Kelly
et al., 2006; Wickham et al., 2007a).
In addition to NleC from A/E pathogens, we detected
NleC homologues in diverse non-E. coli pathogens by
BLASTP analysis, including Salmonella enterica ssp.
Enterica, Arsenophonus nasoniae, a pathogen of wasps
and the aquatic pathogens, Yersinia aldovae and Photo-
bacterium damselae ssp. Piscicida, all which have a T3SS
(do Vale et al., 2005; Switt et al., 2009; Chen et al., 2010;
Wilkes et al., 2010). The NleC homologue from P. dam-
selae has been described previously as AIP56 for
apoptosis-inducing protein 56 and this effector is required
for the induction of apoptosis in phagocytes from sea bass
(do Vale et al., 2005). Although amino acid similarity
between NleC and AIP56 is only 58%, the metallopro-
tease active site is present and it is tempting to speculate
that AIP56 targets NF-kB-like proteins for degradation,
thereby inducing apoptosis (do Vale et al., 2005). Indeed
NleC is not the first T3SS effector reported to target
NF-kB. The tail-specific protease, CT441, from Chlamydia
trachomatis is a T3SS protease that cleaves human p65
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during infection of epithelial cells thereby inhibiting the
host inflammatory response (Lad et al., 2007). For EPEC,
the combined effects of NleE and NleC appear to allow
the pathogen to exert exquisite control of NF-kB signalling
stimulated by both TLR and death receptor signalling, and
despite the fact that inflammation ultimately results from
infection with EPEC, these effectors may allow the patho-
gen to delay innate immune responses long enough
to establish infection and disseminate to other hosts
(Wickham et al., 2007b).
Experimental procedures
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are
listed in Table S1. Bacteria were grown at 37°C in Luria–
Bertani (LB) medium or Dulbecco’s modified Eagle’s
(DMEM) where indicated and supplemented with ampicillin
(100 mg ml-1), kanamycin (100 mg ml-1) or chloramphenicol
(25 mg ml-1) when necessary.
HeLa cell infection and IL-8 secretion
HeLa cells were cultured in T75 cm2 tissue culture flasks
(Triple Red, UK) in DMEM supplemented with 10% FBS
and 5% HEPES, 100 U ml-1 penicillin and 100 mg ml-1 strep-
tomycin in 5% CO2 at 37°C. Sixteen to 24 h before either
transfection or infection, cells were seeded onto 12 mm
glass coverslips (Menzel-Glaser, Braunschweig, Germany)
within 24-well tissue culture trays (Greiner Bio-One,
Germany) at a density of 105 cells per well. For infection,
EPEC derivatives were grown in Luria broth (LB) for 8 h
before being subcultured into DMEM and incubated station-
ary for approximately 16 h at 37°C with 5% CO2. Ten
microlitres of this culture, OD600 = 1.0 nm, was used to infect
each well for 2 h, 4 h or 6 h as indicated (~5 ¥ 106 cfu). For
analysis of IL-8 secretion, monolayers were infected for 4 h
before being incubated for 8–12 h in media supplemented
with 50 mg ml-1 gentamicin with or without 20 ng ml-1 TNF
(Calbiochem, EMD4Biosciences, USA). IL-8 secretion into
cell culture supernatants was measured by ELISA according
to the manufacturer’s instructions (R&D Systems, Minne-
apolis, MN). Differences in IL-8 secretion were assessed for
significance by one-way analysis of variance (ANOVA) with
Tukey’s Multiple Comparison post-test.
DNA cloning, purification and sequence analysis
DNA-modifying enzymes were used in accordance with the
manufacturer’s recommendations (Roche). PCR amplifica-
tion consisted of an initial denaturation step at 94°C for
2 min, followed by 30 cycles of 44 s at 94°C, 40 s at 40°C
and 1 min at 70°C. PCR products and restriction digests
were purified using the Wizard® SV Gel and PCR Clean-Up
System (Promega, WI). The nleC gene of EPEC E2348/69
was amplified from genomic DNA by PCR using the primer
pair NleCF/NleCR (Table S2). The PCR product was digested
with EcoRI/BamHI and ligated into pEGFP–C2 to generate
an N-terminal GFP fusion to NleC (pGFP–NleC). pGFP–
NleF and pGFP–NleG were constructed using an identical
strategy to pGFP–NleC with EPEC E2348/69 as a template
and the primer pairs NleFF/NleFR, NleGF/NleGR respectively.
To generate the complementing vector, pNleC, nleC from
pGFP–NleC was digested with EcoRI and BamHI and ligated
into pTrc99A. To generate the complementing vector, pNleD,
nleD from EPEC E2348/69 was amplified from genomic DNA
by PCR using the primer pair NleDF/NleDR (Table S2).
pNleCAEIIA was created using the Stratagene Quickchange II
Site-Directed Mutagenesis Kit. pNleC was used as template
DNA and amplified by PCR using the primer pair
pNleC(AEIIA)F/pNleC(AEIIA)R (Table S2). N-terminal His6 tagged
versions of NleC and NleCAEIIA were generated by amplifying
DNA from pEGFP–NleC or pEGFP–NleCAEIIA by PCR using
the primer pair NleCF/NleCR. The products were cloned into
the EcoRI/SalI restriction sites of pET28a.
Preparation of His6-NleC and His6-NleCAEIIA and
protease activity in HeLa lysates
Overnight cultures of BL21 (pET-NleC) and BL21
(pET-NleCAEIIA) grown in LB were diluted 1:100 in 200 ml of
LB supplemented with kanamycin (100 mg ml-1) with shaking
to an optical density of (A600) 0.6 at 37°C. Cells were induced
with 1 mM IPTG and grown for a further 2 h then pelleted by
centrifugation. Proteins were purified by nickel affinity chro-
matography in accordance with the manufacturer’s instruc-
tions (Novagen, EMD4Biosciences, USA). Elution fractions
had a total protein content of 1 mg ml-1.
HeLa cells were cultured for 48 h in 100 mm tissue culture
dishes (Greiner Bio-One, Germany) in DMEM supplemented
with 10% FBS and 5% HEPES, 100 U ml-1 penicillin and
100 mg ml-1 streptomycin in 5% CO2 at 37°C. Cells were
collected in 600 ml of PBS using a cell scraper to detach the
adherent monolayer followed by passage 30 times through a
22-inch needle for lysis. The lysate was kept on ice for 10 min
before being transferred to a microfuge tube and centrifuged
for 10 min at 4°C. The supernatant was removed to a sepa-
rate tube and 100 ml aliquots were incubated at 37°C with
varying amounts of His6-NleC or His6-NleCAEIIA ranging from
0.01 mg to 1 mg for a period of 4 h. Degradation of cellular p65
and/or p50 was determined by immunoblot. Sample buffer
was added to each tube, boiled and 15 ml was loaded onto
10% SDS-PAGE gels. Proteins were transferred to nitrocel-
lulose membranes and probed with either rabbit polyclonal
anti-p50 (Cell Signaling), rabbit polyclonal anti-p65 (Santa
Cruz) or rabbit polyclonal anti-calnexin (Santa Cruz) diluted
1:1000 in TBS with 5% BSA (Sigma) and 0.1% Tween
(Amresco). Proteins were detected using anti-rabbit IgG alka-
line phosphatise-conjugated secondary antibodies (Sigma)
diluted 1:5000 in TBS with 5% BSA and 0.1% Tween and
developed with NBT/BCIP substrate (Thermo Scientific,
Rockford, IL).
Construction of EPEC E2348/69 nleC/nleE
double mutant
The nleC gene was disrupted using the l Red recombinase
system in an EPEC E2348/69 DnleE background. Briefly, the
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kanamycin-resistance gene was amplified from pKD4 using
the primers DnleCF and DnleCR (Table S2). PCR products
were DpnI digested before being electroporated into EPEC
E2348/69 DnleE carrying the Red recombinase expression
plasmid, pKD46. Mutants were selected from LB plates
supplemented with chloramphenicol and kanamycin and veri-
fied by PCR and sequencing for the replacement of nleC with
the kanamycin-resistance gene.
Immunofluorescence, fluorescence actin staining test
and confocal microscopy
HeLa cells were transfected with plasmids using Lipo-
fectamine 2000 (Invitrogen, Carlsbad CA, USA) according to
the manufacturer’s specifications. Transfected HeLa cells
were left unstimulated or stimulated with 20 ng ml-1 TNF
(Calbiochem) for 30 min at 37°C and 5% CO2. Transfected
or infected cells were fixed with 3.7% (w/v) formaldehyde
(Sigma) in PBS for 10 min and permeabilized with 1:1 (v/v)
methanol-acetone at -20°C for 15 min. Cells were then
blocked in PBS with 3% (w/v) BSA (Sigma) for 30 min. For
visualization of NF-kB p65 in transfected cells, a rabbit poly-
clonal anti-p65 (SC-109, Santa Cruz, CA, USA) antibody was
applied at 1:100 in PBS with 3% (w/v) BSA for 1 h at 20°C.
Alexa Fluor 488 or Alexa Fluor 568 (Invitrogen) conjugated
anti-rabbit immunoglobulin G was used as secondary
antibodies at 1:2000 for 1 h at 20°C. 4′,6-Diamidino-2-
phenylindole (DAPI; Invitrogen) was applied at a dilution of
1:20000 in blocking solution for 5 min at room temperature
post secondary antibody treatment and coverslips were
mounted on glass slides with Fluorescence Mounting
Medium (Dako, Carpinteria, CA). For infected HeLa cells, the
fluorescence actin staining (FAS) test was achieved by fixing
and permeabilizing as described above and including
0.5 mg ml-1 phalloidin conjugated to rhodamine (Sigma)
during the primary antibody incubation. Images were
acquired using a confocal laser scanning microscope (Leica
LCS SP2 confocal imaging system) with a 100¥/1.4 NA HCX
PL APO CS oil immersion objective.
Detection of Rel proteins by immunoblot
To test the effect of NleC on host signalling factors, HeLa
cells were infected with derivatives of EPEC E2348/69 for 2,
4 or 6 h. Cells were lysed with 60 ml of lysis buffer (50 mM
Tris-HCl pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% Triton
X-100, 2 mM Na3VO4, 10 mM NaF, 1 mM PMSF, Roche Com-
plete Protease Inhibitor EDTA-free) by incubation on ice for
5 min before the lysate was transferred to a microfuge tube
and incubated on ice for a further 10 min. The lysate was
centrifuged for 10 min at 4°C and equal volumes of superna-
tant were removed to a tube containing sample buffer, boiled
for 5 min before loaded onto 10% SDS-PAGE gels. Proteins
were transferred to nitrocellulose membranes and probed
with one of the following antibodies: rabbit polyclonal anti-c-
Rel, rabbit polyclonal anti-p50, mouse monoclonal anti-Stat1
9H2 (Cell Signaling), rabbit polyclonal anti-p65 (Santa Cruz),
mouse monoclonal anti-b-actin AC-15 (Sigma), mouse mono-
clonal anti-ERK clone 16 (BD Biosciences) or rabbit poly-
clonal anti-Calnexin (Stressgen). Actin or calnexin was used
as loading controls. All antibodies were diluted 1:1000 in TBS
with 5% BSA (Sigma) and 0.1% Tween (Amresco). Proteins
were detected using anti-rabbit or mouse IgG alkaline
phosphatise-conjugated secondary antibodies (Sigma) and
developed with NBT/BCIP substrate (Thermo Scientific,
Rockford, IL). All secondary antibodies were diluted 1:5000 in
TBS with 5% BSA (Sigma) and 0.1% Tween (Amresco).
For quantification of band intensity, proteins were detected
using peroxidase-conjugated secondary antibodies and
developed with SuperSignal® West Pico Chemiluminescent
Substrate (Thermo Scientific). Images were visualized using
a Kodak Image Station 4000MM (IS4000MM) and processed
using Carestream Molecular Imaging Software v5.0.2. Mean
intensity data for bands were acquired by selecting regions of
interest and subtracting background membrane intensity. For
each time point values were normalized to protein levels of
uninfected cells at that time point. Differences in band inten-
sity were assessed for significance by one-way ANOVA with
Tukey’s Multiple Comparison post-test.
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